Dopamine D2 Receptor Agonists: Small Molecules and Peptides
DRD2 encodes the D2 subtype of the dopamine receptor that inhibits adenylyl cyclase activity. Alternative splicing of this G protein-coupled receptor results in two transcript variants encoding different isoforms. DRD2 plays a major role in the neural circuitry that mediates behavioral control, an ability that is essential for adaptive responding and is compromised in a variety of common neuropsychiatric disorders.
3 results for "Dopamine D2 Receptor Agonists Small Molecules and Peptides" in Products
3 results for "Dopamine D2 Receptor Agonists Small Molecules and Peptides" in Products
Dopamine D2 Receptor Agonists: Small Molecules and Peptides
DRD2 encodes the D2 subtype of the dopamine receptor that inhibits adenylyl cyclase activity. Alternative splicing of this G protein-coupled receptor results in two transcript variants encoding different isoforms. DRD2 plays a major role in the neural circuitry that mediates behavioral control, an ability that is essential for adaptive responding and is compromised in a variety of common neuropsychiatric disorders.
| Chemical Name: | 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone |
| Purity: | ≥99% (HPLC) |
| Alternate Names: | N 0923 |
| Chemical Name: | (6S)-5,6,7,8-Tetrahydro-6-[propyl[2-(2-thienyl)ethyl]amino]-1-naphthalenol hydrochloride |
| Purity: | ≥99% (HPLC) |
| Chemical Name: | (R)-5,6-Dihydro-5-(methylamino)-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one (2Z)-2-butenedioate |
| Purity: | ≥98% (HPLC) |
